The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration

被引：0
|
作者：
Attila Kovacs
Timea Kiss
Ferenc Rarosi
Gabor M. Somfai
Andrea Facsko
Rozsa Degi
机构：
[1] University of Szeged,Department of Ophthalmology, Faculty of Medicine
[2] University of Szeged,Department of Medical Physics and Informatics, Faculty of Medicine
[3] Augenzentrum Pallas Kliniken,Department of Ophthalmology, Faculty of Medicine
[4] Semmelweis University,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Outer retinal tubulation; Prevalence; Anti-VEGF; Aflibercept; Retreatment; Subretinal hyperreflective material;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [32] Response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory ranibizumab
    Ogata, N.
    Hasegawa, T.
    Yamashita, M.
    Okamoto, M.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [33] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [34] Intravitreal aflibercept outcomes in patients with persistent retinal fluid with prior bevacizumab or ranibizumab treatment for neovascular age-related macular degeneration
    Griffin, David
    Richmond, Preston
    Olson, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [35] Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration Data from the Fight Retinal Blindness! Registry
    Bhandari, Sanjeeb
    Nguyen, Vuong
    Arnold, Jennifer
    Young, Stephanie
    Banerjee, Gayatri
    Gillies, Mark
    Barthelmes, Daniel
    OPHTHALMOLOGY, 2020, 127 (03) : 369 - 376
  • [36] Conversion to aflibercept for patients with neovascular age-related macular degeneration who were refractory to ranibizumab treatment
    Kawashima, Yu
    Oishi, Akio
    Miyake, Masahiro
    Yoshikawa, Munemitsu
    Takahashi, Ayako
    Ueda, Naoko
    Tamura, Hiroshi
    Yamashiro, Kenji
    Tsujikawa, Akitaka
    Yoshimura, Nagahisa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [37] Relationship of Retinal Morphology and Retinal Sensitivity in the Treatment of Neovascular Age-Related Macular Degeneration Using Aflibercept
    Sulzbacher, Florian
    Roberts, Philipp
    Munk, Marion R.
    Kaider, Alexandra
    Kroh, Maria Elisabeth
    Sacu, Stefan
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (02) : 1158 - 1167
  • [38] Prevalence of Outer Retinal Tubulation After Anti-VEGF Therapy for Age-Related Macular Degeneration
    Gildener-Leapman, Juliana R.
    Srivistava, Sunil
    Ehlers, Justis P.
    Kaiser, Peter K.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (03): : 345 - 348
  • [39] Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration
    Nita, Malgorzata
    Michalska-Malecka, Katarzyna
    Mazurek, Urszula
    Kimsa, Malgorzata
    Strzalka-Mrozik, Barbara
    Grzybowski, Andrzej
    Romaniuk, Dorota
    MEDICAL SCIENCE MONITOR, 2014, 20 : 875 - 883
  • [40] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
12345